{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:34:35Z","timestamp":1776864875197,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1007\/bf01007833","type":"journal-article","created":{"date-parts":[[2005,1,19]],"date-time":"2005-01-19T08:27:44Z","timestamp":1106123264000},"page":"20-26","source":"Crossref","is-referenced-by-count":22,"title":["The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%"],"prefix":"10.1007","volume":"235","author":[{"given":"Michael","family":"Diestelhorst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Roters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\ufffdnter K.","family":"Krieglstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/archopht.1991.01080110100045","volume":"109","author":"A Alm","year":"1991","unstructured":"Alm A, Villumsen J (1991) PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol 109:1564?1568","journal-title":"Arch Ophthalmol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0161-6420(93)31482-X","volume":"100","author":"A Alm","year":"1993","unstructured":"Alm A, Villumsen J, T\u00f6rnquist P, Mandahl A, Airaksinen J, Tuulonen A, Marsk A, Resul B, Stjernschantz J (1993) Intraocular pressure reducing effect of PhXA41 in patients with increased eye pressure: a one-month study. Ophthalmology 100:1312?1317","journal-title":"Ophthalmology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J, Scandinavian Latanoprost Study Group (1995) Effects on intraocular pressure and side effects of 0.005% Latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 102:1743?1752","journal-title":"Ophthalmology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/bjo.79.1.12","volume":"79","author":"A Alm","year":"1995","unstructured":"Alm A, Wideng\u00e5rd I, Kjellgren D, S\u00f6derstr\u00f6m M, Fristrum B, Heijl A, Stjernschantz J (1995) Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol 79:12?16","journal-title":"Br J Ophthalmol"},{"key":"CR5","first-page":"52","volume-title":"Glaucoma update IV","author":"M Araie","year":"1990","unstructured":"Araie M, Mori M, Oshika T (1990) In vivo measurements of aqueous flare in human eyes. Diurnal variation and drug effects. In: Krieglstein GK (ed) Glaucoma update IV. Springer, Berlin Heidelberg New York, pp 52?56"},{"key":"CR6","first-page":"349","volume":"312","author":"LZ Bito","year":"1989","unstructured":"Bito LZ, Camras CB, Gum GG, Resul B (1989) The ocular hypotensive effects of topically applied prostaglandins on eyes of experimental animals. Prog Clin Biol Res 312:349?368","journal-title":"Prog Clin Biol Res"},{"key":"CR7","first-page":"477","volume-title":"The ocular effects of prostaglandins and other eicosanoids","author":"RF Brubaker","year":"1989","unstructured":"Brubaker RF (1989) Fluorophotometric studies of prostaglandin effects on the human eye: the lack of association of reduced intraocular pressure with altered flow of barrier function. In: Bito LZ, Stjernschantz J (eds) The ocular effects of prostaglandins and other eicosanoids. Liss, New York, pp 477?481"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, United States Latanoprost Study Group (1996) Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 103: 138?147","journal-title":"Ophthalmology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3109\/02713688709034874","volume":"6","author":"K Crawford","year":"1987","unstructured":"Crawford K, Kaufman PL, Gabelt BT (1987) Effects of topical PGF2? on aqueous humour dynamics in cynomolgus monkeys. Curr Eye Res 6:1034?1044","journal-title":"Curr Eye Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0886-3350(96)80163-5","volume":"22","author":"M Diestelhorst","year":"1996","unstructured":"Diestelhorst M, Schmidt B, Konen W, Mester U, Sunder Raj P (1996) Efficacy and tolerance of diclofenac sodium 0.1 %, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation. J Cataract Refract Surg 22:788?793","journal-title":"J Cataract Refract Surg"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archopht.1993.01090050096037","volume":"111","author":"B Fristr\u00f6m","year":"1993","unstructured":"Fristr\u00f6m B, Nilsson SEG (1993) Interaction of PhXA41 a new prostaglandin analogue with pilocarpine. A study in patients with elevated intraocular pressure. Arch Ophthalmol 111:662?665","journal-title":"Arch Ophthalmol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-4835(89)90049-3","volume":"49","author":"BT Gabelt","year":"1989","unstructured":"Gabelt BT, Kaufman PL (1989) Prostaglandin F2? increases inveoscleral outflow in the cynomolgus monkey. Exp Eye Res 49:389?402","journal-title":"Exp Eye Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-4835(90)90174-S","volume":"51","author":"BT Gabelt","year":"1990","unstructured":"Gabelt BT, Kaufman PL (1990) The effect of prostaglandin F2? on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res 51:87?91","journal-title":"Exp Eye Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02173538","volume":"222","author":"G Giuffr\u00e9","year":"1985","unstructured":"Giuffr\u00e9 G (1985) The effects of prostaglandin F2? in the human eye. Graefes Arch Clin Exp Ophthalmol 222:139?141","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"CR15","first-page":"259","volume":"37","author":"Y Hotehama","year":"1993","unstructured":"Hotehama Y, Mishima HK (1993) Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2?-isopropyl ester analogues for glaucoma treatment. Jpn J Ophthal mol 37:259?269","journal-title":"Jpn J Ophthal mol"},{"key":"CR16","first-page":"270","volume":"37","author":"Y Hotehama","year":"1993","unstructured":"Hotehama Y, Mishima HK, Kitazawa Y, Masuda K (1993) Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma. Jpn J Ophthalmol 37:270?274","journal-title":"Jpn J Ophthalmol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0420.1995.tb00274.x","volume":"73","author":"D Kjellgren","year":"1995","unstructured":"Kjellgren D, Douglas G, Mikelberg FS, Drance SM, Alm A (1995) The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma. Acta Ophthalmol 73:233?236","journal-title":"Acta Ophthalmol"},{"key":"CR18","unstructured":"Lasky M, Ticho U, Nesher R, Melamed S, Glovinsky J (1994) Comparison of two dose regimens of latanoprost in patients with open-angle glaucoma or ocular hypertension. Abstract SP576, Proceedings of 27th International Congress of Ophthalmology, Toronto, Canada, June"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0161-6420(13)31817-X","volume":"100","author":"S Nagasubramanian","year":"1993","unstructured":"Nagasubramanian S, Sheth GP, Hitchings RA, Stjernschantz J (1993) Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Ophthalmology 100:1305?1311","journal-title":"Ophthalmology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0014-4835(89)90011-0","volume":"48","author":"SFE Nilsson","year":"1989","unstructured":"Nilsson SFE, Samuelsson M, Bill A, Stjernschantz J (1989) Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2? 1-isopropylester in the cynomolgus monkey. Exp Eye Res 48:707?716","journal-title":"Exp Eye Res"},{"key":"CR21","doi-asserted-by":"crossref","unstructured":"Sel\u00e9n G, Stjernschantz J, Resul B (1996) Prostaglandin-induced iridial pigmentation in primates. Surv Ophthalmol (in press)","DOI":"10.1016\/S0039-6257(97)80019-7"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1358\/dof.1992.017.08.187766","volume":"17","author":"J Stjernschantz","year":"1992","unstructured":"Stjernschantz J, Resul B (1992) Phenyl substituted prostaglandin analogs for glaucoma treatment. Drugs Future 17:691?704","journal-title":"Drugs Future"},{"key":"CR23","first-page":"155","volume-title":"The ocular effects of prostaglandins and other eicosanoids","author":"J Stjernschantz","year":"1989","unstructured":"Stjernschantz J, Nilsson SFE, Astin M (1989) Vasodynamic and angiogenic effects of eicosanoids in the eye. In: Bito LZ, Stjernschantz J (eds) The ocular effects of prostaglandins and other eicosanoids. Liss, New York, pp 155?170"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archopht.1986.01050180133045","volume":"104","author":"M Stur","year":"1986","unstructured":"Stur M, Grabner G, Huber-Spitzy V, Schreiner J, Haddad R (1986) Effect of timolol on aqueous humour protein concentration in the human eye. Arch Ophthalmol 104:899?900","journal-title":"Arch Ophthalmol"},{"key":"CR25","first-page":"623","volume":"87","author":"E Tamm","year":"1990","unstructured":"Tamm E, Rittig M, L\u00fctjen-Drecoll E (1990) Elektromikroskopische und immunohistochemische Untersuchungen zur augendrucksenkenden Wirkung von Prostaglandin F2?. Fortschr Ophthalmol 87:623?629","journal-title":"Fortschr Ophthalmol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","volume":"100","author":"CB Toris","year":"1993","unstructured":"Toris CB, Camras CB, Yablonski ME (1993) Effects of PhXA41, a new prostaglandin F2? analog, on aqueous humour dynamics in human eyes. Ophthalmology 100:1297?1304","journal-title":"Ophthalmology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bjo.73.6.419","volume":"73","author":"J Villumsen","year":"1989","unstructured":"Villumsen J, Alm A (1989) Prostaglandin F2?-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol 73:419?425","journal-title":"Br J Ophthalmol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.76.4.214","volume":"76","author":"J Villumsen","year":"1992","unstructured":"Villumsen J, Alm A (1992) PhXA34 a prostaglandin F2? analogue. Effect on intraocular pressure in patients with ocular hypotension. Br J Ophthalmol 76:214?217","journal-title":"Br J Ophthalmol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bjo.73.12.975","volume":"73","author":"J Villumsen","year":"1989","unstructured":"Villumsen J, Alm A, S\u00f6derstr\u00f6m M (1989) Prostaglandin F2?-isopropy-tester eye drops: effect on intraocular pressure in open-angle glaucoma. Br J Ophthalmol 73:975?979","journal-title":"Br J Ophthalmol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J, Latanoprost Study Group (1996) A sixmonth, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103:126?137","journal-title":"Ophthalmology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archopht.1993.01090100059027","volume":"111","author":"N Ziai","year":"1993","unstructured":"Ziai N, Dolan JW, Kacere RD, Brubaker RF (1993) The effects on aqueous dynamics of PhXA41, a new prostaglandin F2? analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 111:1351?1358","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01007833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01007833\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01007833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T10:45:00Z","timestamp":1586083500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01007833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BF01007833"],"URL":"https:\/\/doi.org\/10.1007\/bf01007833","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}